GW Pharma Wants Out Of Canopy's CBD Patent Dispute

GW Pharmaceuticals has asked a Texas federal court to toss a patent suit brought by Canadian cannabis company Canopy Growth over the flagship CBD drug Epidiolex, arguing that the court has...

Already a subscriber? Click here to view full article